Healthcare -
Medical - Healthcare Information Services - NASDAQ - US
$ 113.89
-4.29 %
$ 633 M
Market Cap
9.22
P/E
1. INTRINSIC VALUE
Balance Sheet
Nutex Health, Inc.
| Current Assets | 292 M |
| Cash & Short-Term Investments | 43.6 M |
| Receivables | 236 M |
| Other Current Assets | 12.8 M |
| Non-Current Assets | 363 M |
| Long-Term Investments | 0 |
| PP&E | 325 M |
| Other Non-Current Assets | 38.1 M |
| Current Liabilities | 141 M |
| Accounts Payable | 14 M |
| Short-Term Debt | 27.7 M |
| Other Current Liabilities | 99.2 M |
| Non-Current Liabilities | 313 M |
| Long-Term Debt | 313 M |
| Other Non-Current Liabilities | 0 |
EFFICIENCY
Earnings Waterfall
Nutex Health, Inc.
| Revenue | 480 M |
| Cost Of Revenue | 284 M |
| Gross Profit | 196 M |
| Operating Expenses | 65.6 M |
| Operating Income | 131 M |
| Other Expenses | 78.4 M |
| Net Income | 52.2 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Nutex Health, Inc.
| Net Income | 52.2 M |
| Depreciation & Amortization | 19 M |
| Capital Expenditures | -2.3 M |
| Stock-Based Compensation | 16.6 M |
| Change in Working Capital | -104 M |
| Others | 182 B |
| Free Cash Flow | 20.8 M |
Wall Street Analysts Price Targets
Nutex Health, Inc.
Wall Street analysts predict an average 1-year price target for NUTX of $45 , with forecasts ranging from
a
low of
$45 to a high of $45 .
NUTX Lowest Price Target
Wall Street Target
45 USD
-60.49%
NUTX Average Price Target
Wall Street Target
45 USD
-60.49%
NUTX Highest Price Target
Wall Street Target
45 USD
-60.49%
4. DIVIDEND
ANALYSIS
NUTX does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Nutex Health, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
81.8 K USD 1
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
102 K USD 4
9-12 MONTHS
7. News
Nutex Health Leverages Arbitration To Unlock Hidden Value
Nutex Health is a speculative buy, exploiting a unique arbitrage model under the No Surprises Act for strong revenue and profit growth. The micro-hospital strategy, physician ownership, and focus on efficiency drive staff stability and operational expansion, supporting sustainable volume growth. Financials are robust: Q1 saw a 213% sales jump, a 56% gross margin, strong cash flow, and a healthy balance sheet with modest debt.
seekingalpha.com
- 2 weeks ago
NUTEX HEALTH ANNOUNCES INTERNET AVAILABILITY OF PROXY MATERIALS FOR ITS 2025 ANNUAL MEETING
HOUSTON , June 2, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced the availability of its definitive proxy materials for its 2025 annual meeting to be held on July 14, 2025 at 10:00 am Central Time via the internet as a virtual meeting only (and not in person) at www.virtualshareholdermeeting.com/NUTX2025 . We look forward to hosting you at our virtual shareholder meeting and encourage you to participate and vote.
prnewswire.com
- 1 month ago
Nutex Health Inc.: High-Growth Healthcare Innovator With Strong Momentum
NUTX is transforming from a turnaround story to a high-growth, high-risk play, driven by explosive revenue and profitability from its micro-hospital model. The company's financials show triple-digit revenue growth, margin expansion, and strong operating leverage, with positive analyst sentiment and technical momentum. Key risks include heavy reliance on arbitration revenue, significant lease liabilities, and regulatory uncertainty, making this a volatile but compelling opportunity.
seekingalpha.com
- 1 month ago
NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF GRANT THORNTON LLP AS ITS INDEPENDENT AUDITOR
HOUSTON , May 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Grant Thornton LLP ("Grant Thornton") as the Company's independent registered public accounting firm to replace CBIZ CPAs ("CBIZ"), effective May 15, 2025. The change of the Company's independent auditor was made after careful consideration and an evaluation process and was approved by the Audit Committee and the Board of Directors of the Company.
prnewswire.com
- 1 month ago
Nutex Health Inc. (NUTX) Q1 2025 Earnings Conference Call Transcript
Nutex Health Inc. (NASDAQ:NUTX ) Q1 2025 Earnings Conference Call May 14, 2025 10:30 AM ET Company Participants Jennifer Rodriguez - IR Manager Tom Vo - Chairman and CEO Jon Bates - CFO Warren Hosseinion - President Josh DeTillio - COO Conference Call Participants Bill Sutherland - The Benchmark Company Thomas McGovern - Maxim Group Gene Mannheimer - Freedom Capital Markets Joshua Cohen - Westbury Capital Operator Greetings. Welcome to Nutex Health's First Quarter 2025 Financial Results Conference Call.
seekingalpha.com
- 1 month ago
NUTEX HEALTH REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8% NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET LOSS OF $0.4 MILLION IN Q1 2024 DILUTED EPS OF $2.56 PER SHARE VERSUS $(0.08) PER SHARE IN Q1 2024 EBITDA OF $43.1 MILLION VERSUS $7.1 MILLION IN EBITDA IN Q1 2024, AN INCREASE OF 507.0% ADJUSTED EBITDA OF $72.8 MILLION VERSUS $(0.4) MILLION IN Q1 2024 NET CASH FROM OPERATING ACTIVITIES OF $51.0 MILLION COMPANY BELIEVES ITS ARBITRATION EFFORTS THROUGH THE INDEPENDENT DISPUTE RESOLUTION (IDR) PROCESS HAVE RESULTED IN MORE FAIR AND REASONABLE PAYMENTS HOUSTON , May 13, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced first quarter 2025 financial results for the three months ended March 31, 2025.
prnewswire.com
- 1 month ago
Nutex Health Schedules 2025 First Quarter Financial Results Release and Conference Call
HOUSTON , May 7, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the first quarter ended March 31, 2025 after the close of the stock market on Tuesday, May 13, 2025. The Company will discuss those results on a conference call on Wednesday, May 14, 2025, at 10:30 a.m.
prnewswire.com
- 1 month ago
Nutex Health Achieves Blowout Earnings On Arbitration Win But There Are Too Many Unknowns
Nutex Health Inc. reported a significant revenue increase of 270% year-over-year in Q4. The company's GAAP EPS was an impressive $11.12 for Q4 and $9.71 for the year, implying that it's trading at a bargain at first glance. The company's earnings were driven to be a substantial set of arbitration wins, with no guarantee that this will continue going forward.
seekingalpha.com
- 3 months ago
Nutex Health Inc. (NUTX) Q4 2024 Earnings Call Transcript
Nutex Health Inc. (NASDAQ:NUTX ) Q4 2024 Earnings Conference Call April 1, 2025 10:30 AM ET Company Participants Jennifer Rodriguez - Corporate Director of Marketing and Business Development Tom Vo - Chairman and Chief Executive Officer Jon Bates - Chief Financial Officer Warren Hosseinion - President Josh DeTillio - Chief Operating Office Conference Call Participants Bill Sutherland - The Benchmark Company Carl Byrnes - Northland Capital Markets Anthony Vendetti - Maxim Group Gene Mannheimer - Freedom Capital Markets Operator Greetings, and welcome to the Nutex Health Fourth Quarter 2024 Financial Results Call. At this time all participants are in a listen-only mode.
seekingalpha.com
- 3 months ago
NUTEX HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
FULL YEAR 2024 HIGHLIGHTS: TOTAL REVENUE OF $479.9 MILLION VERSUS $247.6 MILLION IN 2023, AN INCREASE OF 93.8% NET INCOME OF $52.2 MILLION VERSUS NET LOSS OF $45.8 MILLION IN 2023 DILUTED EPS OF $9.71 PER SHARE VERSUS $(10.39) PER SHARE IN 2023 EBITDA OF $98.4 MILLION VERSUS $(22.5) MILLION IN EBITDA IN 2023 ADJUSTED EBITDA OF $123.7 MILLION VERSUS $10.8 MILLION IN 2023, AN INCREASE OF 1,045.4% NET CASH FROM OPERATING ACTIVITIES OF $23.2 MILLION COMPANY BELIEVES ITS ARBITRATION EFFORTS, THROUGH THE INDEPENDENT DISPUTE RESOLUTION (IDR) PROCESS, HAS RESULTED IN MORE EQUITABLE PAYMENTS HOUSTON , March 31, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced fourth quarter 2024 and fiscal year 2024 financial results for the twelve months ended December 31, 2024. Financial highlights for the year ended December 31, 2024: Total revenue increased $232.3 million to $479.9 million for the year ended December 31, 2024 as compared to total revenue of $247.6 million for the same period in 2023, an increase of 93.8%.
prnewswire.com
- 3 months ago
NUTEX HEALTH RESCHEDULES EARNINGS RELEASE AND CONFERENCE CALL
HOUSTON , March 27, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX) announced that it has rescheduled the release of its financial results and conference call related to the fourth quarter and full year ended December 31, 2024, which had previously been scheduled for March 27, 2025 and March 28, 2025, respectively. Nutex currently expects to issue its fourth quarter and full year 2024 financial results after market close on Monday, March 31, 2025, the official SEC filing deadline.
prnewswire.com
- 3 months ago
Nutex Health to Present at the EDPMA Solutions Summit 2025
HOUSTON , March 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro-hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced its CEO, Dr. Tom Vo, will present at the EDPMA Solutions Summit 2025. This event will take place from March 30 to April 2 at The Broadmoor in Colorado Springs, CO.
prnewswire.com
- 3 months ago
8. Profile
Summary
Nutex Health, Inc. NUTX
COUNTRY
US
INDUSTRY
Medical - Healthcare Information Services
MARKET CAP
$ 633 M
Dividend Yield
0.00%
Description
Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.
Contact
6030 South Rice Avenue, Houston, TX, 77081
https://www.nutexhealth.com
IPO
Date
April 4, 2022
Employees
800
Officers
Ms. Pamela W. Montgomery B.S.N., J.D., L.L.M., M.S.N., R.N.
Chief Legal Officer of Healthcare & Board Secretary
Mr. Joshua DeTillio FACHE, M.B.A.
Chief Operating Officer
Dr. Thomas T. Vo M.B.A., M.D.
Chairman of the Board & Chief Executive Officer
Ms. Sarah Wallace
Director of Human Resources
Dr. Michael Chang M.D.
Chief Medical Officer
Mr. Jon C. Bates CPA, M.B.A.
Chief Financial Officer
Ms. Vivian Sanders M.B.A.
Director of Marketing
Dr. Warren Hosseinion M.D.
President & Director
Jennifer Rodriguez
Investor & Public Relations Manager
Ms. LaTanya Brackens
Director of Compliance